Microbot Medical MBOT 深 沪
等待开盘 10-03 09:30:00 美东时间
1.145
-0.055
-4.58%
华盛通- 最 高1.23
- 今 开1.23
- 成交量 64.68万股
- 最 低 1.14
- 昨 收 1.20
- 总市值 7690.37万
- 52周最高 3.04
- 市盈率 静 --
- 换手率 0.96%
- 52周最低 1.14
- 委 比 44.12%
- 总股本 6716.48万
- 历史最高 149.10
- 量 比 1.55
- 振 幅 7.50%
- 历史最低 0.82
- 每 手 1
- 风险率 0.42%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Microbot Medical Updates Growth Strategy via Regulation FD Disclosure
An update from Microbot Medical ( ($MBOT) ) is now available. Microbot Medical ...
09-28 18:47
Microbot Medical® Highlights Growth Strategy
Microbot Medical Inc. highlighted its commercial growth strategy during an analyst meeting, including high user satisfaction with its LIBERTY System, expansion of U.S. sales territories to 12 by year-end, and plans to enter California and North Carolina markets. The company is engaging Value Analysis Committees to accelerate hospital access and has hired additional sales leaders to support westward expansion. Operational efficiencies, such as a s...
09-25 21:30
美股大行评级 | 富国上调闪迪目标价从1400美元升至1550美元；塔吉特、Workday、应用材料等获多家大行上调目标价
今日重点评级关注：富瑞：维持ProMIS Neurosciences"买入"评级，目标价从69美元升至100美元；Benchmark：维持Cineverse"买入"评级，目标价从12美元升至14美元
08-17 13:37
Microbot Medical shares are trading lower after the company reported worse-than-expected Q2 sales results.
Microbot Medical shares are trading lower after the company reported worse-than-expected Q2 sales results.
08-11 23:17
Microbot Medical Q2 EPS $(0.08), Inline, Sales $241.000K Miss $340.000K Estimate
Microbot Medical (NASDAQ:MBOT) reported quarterly losses of $(0.08) per share which met the analyst consensus estimate. This is a 20 percent increase over losses of $(0.10) per share from the same period last year. The company reported quarterly sales of $241.000 thousand which missed the analyst co...
08-11 21:24
Microbot Medical Showcased at Society of Robotic Surgery
Microbot Medical ( ($MBOT) ) has provided an update. On July 21, 2026, Microbot...
07-21 20:59
Microbot Medical accelerates LIBERTY growth and expansion
Microbot Medical ( ($MBOT) ) just unveiled an update. In the second quarter of ...
07-07 20:59
Microbot Medical Reports 100% Growth In Revenue, New Clients In Q2
Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY® Endovascular Robotic System, is reporting greater than 100% growth in revenue and new customers for the second quarter ended June 30, 2026, compared to the first quarter ended March 31, 2026.
07-07 20:35
Microbot Medical Inks Agreement With Lovell Government Services To Serve Federal Healthcare Systems
Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY® Endovascular Robotic System, has entered into an agreement with Lovell® Government Services to serve federal healthcare systems, such as those administered by the Veterans Health Administration (VHA), a divisi...
06-16 20:38
美股大行评级 | 火爆！24家大行集体上调派拓网络目标价，最高370美元；大摩上调美光目标价从520美元升至1050美元
火爆！24家大行集体上调派拓网络目标价，最高370美元；大摩上调美光目标价从520美元升至1050美元；犹他美容(ULTA)惨遭12家大行下调目标价>>
06-04 11:36
